Research Funds Go Begging, As NIH Minority Plan Gets Feeble Response

While the agency's program to encourage recruitment of minority investigators is said to be `marvelous,' few grantees apply for it WASHINGTON--Nursing professors Irene Lewis and Faye Whitney think they can spot a good thing. And a program that gives scientists as much as $50,000 a year to add a minority investigator onto National Institutes of Health grants is, as far as they are concerned, one of the best deals around. NIH grantee Whitney, an assistant professor at the University of Pennsylv

Written byJeffrey Mervis
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

NIH grantee Whitney, an assistant professor at the University of Pennsylvania, has recruited investigator Lewis, an associate professor at San Jose State University, to Whitney's study of the effects of depression on stroke patients. The collaboration offers Lewis, an African American, a chance to do research at San Jose State, where "teaching, not research, is the priority." For Whitney, Lewis offers experience that will be invaluable in a study with a large number of inner-city minority subjects.

The minority supplements program should not be viewed as the preferred way for minority investigators to enter the lab, say science administrators who have spent years trying to increase the number of minorities engaged in biomedical research. There's nothing wrong with additional research money and an extra pair of hands at the bench, they say, but those reasons aren't sufficient. "We must avoid telling minorities that the only way they can succeed is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies